Medikit Co.,Ltd. (TYO:7749)

Market Cap	40.12B
Revenue (ttm)	22.82B
Net Income (ttm)	3.00B
Shares Out	14.62M
EPS (ttm)	204.26
PE Ratio	13.44
Forward PE	n/a
Dividend	100.00 (3.64%)
Ex-Dividend Date	Sep 29, 2025

Volume	2,300
Average Volume	11,740
Open	2,755.00
Previous Close	2,745.00
Day's Range	2,732.00 - 2,755.00
52-Week Range	2,362.00 - 2,979.00
Beta	0.18
RSI	65.65
Earnings Date	Nov 12, 2025

About Medikit

Medikit Co.,Ltd. engages in the manufacture and sale of vascular access medical devices. The company offers IV catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath and Mongoose. Its products are used in anesthetic departments, operating theaters, ICUs, and dialysis and cardiology units. The company markets its products through distributors in approximately 20 countries and territories in the Eur...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1973
• Employees: 989
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7749

Financial Performance

In 2024, Medikit's revenue was 22.55 billion, an increase of 3.22% compared to the previous year's 21.85 billion. Earnings were 3.01 billion, a decrease of -1.82%.